Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 1;179(6):838-840.
doi: 10.1001/jamainternmed.2018.7235.

Characteristics of Digital Health Studies Registered in ClinicalTrials.gov

Connie E Chen  1 , Robert A Harrington  1   2 , Sumbul A Desai  1   2 , Kenneth W Mahaffey  1   3 , Mintu P Turakhia  1   2   4
Affiliations

Characteristics of Digital Health Studies Registered in ClinicalTrials.gov

Connie E Chen et al. JAMA Intern Med. .

Abstract

This analysis of digital health studies in ClinicalTrials.gov examines the clinical evidence underlying digital health interventions.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr. Chen reported being employed by Lyra Health and serving as a consultant for and having equity in Vida Health. Dr Harrington reported serving as a consultant for Adverse Events, Amgen, Bayer, Gilead, Merck & Co, Vida Health, and WebMD; performing data safety monitoring for AstraZeneca, BMS, and Janssen; having equity in Element Science and MyoKardia; having a fiduciary role in Scanadu, Signal Path, the American Heart Association, College of the Holy Cross, and Stanford Healthcare; and receiving research grants from CSL Behring, GlaxoSmithKline, Merck & Co, Novartis, Portola, Sanofi, and The Medicines Company. Dr Desai reported being employed by Apple. Dr. Mahaffey reported receiving research grants from Afferent, Amgen, Apple Inc, AstraZeneca, Cardiva Medical Inc, Daiichi Sankyo, Ferring, Google (Verily), Johnson & Johnson, Luitpold, Medtronic, Merck & Co, the National Institutes of Health, Novartis, Sanofi, St. Jude, and Tenax; serving as a consultant for Abbott, Ablynx, Baim Institute, Boehringer Ingelheim, Bristol-Myers Squibb, Cardiometabolic Health Congress, Elsevier, GlaxoSmithKline, Medergy, Medscape, Mitsubishi, MyoKardia, Novo Nordisk, Oculeve, Portola, Radiometer, Springer Publishing, Theravance, University of California San Francisco, and WebMD; and having equity in BioPrint Fitness. Dr Turakhia reported receiving research grants from Medtronic Inc, Research, Janssen Pharmaceuticals, AstraZeneca, the American Heart Association, and Amazon; serving as a consultant for Medtronic Inc and Abbott; and having equity in AliveCor. No other disclosures were reported.

Comment in

References

    1. Turakhia MP, Desai SA, Harrington RA. The outlook of digital health for cardiovascular medicine: challenges but also extraordinary opportunities. JAMA Cardiol. 2016;1(7):743-744. doi: 10.1001/jamacardio.2016.2661 - DOI - PubMed
    1. Ahern DK. Challenges and opportunities of ehealth research. Am J Prev Med. 2007;32(5)(suppl):S75-S82. doi: 10.1016/j.amepre.2007.01.016 - DOI - PubMed
    1. O’Neil A, Cocker F, Rarau P, et al. Using digital interventions to improve the cardiometabolic health of populations: a meta-review of reporting quality. J Am Med Inform Assoc. 2017;24(4):867-879. doi: 10.1093/jamia/ocw166 - DOI - PMC - PubMed
    1. National Institutes of Health ClinicalTrials.gov. https://clinicaltrials.gov/. Accessed June 19, 2017.
    1. National Institutes of Health ClinicalTrials.gov FDAAA 801 requirements. https://clinicaltrials.gov/ct2/search/advanced?cond=&term=&state1=&cntry1=. Accessed June 19, 2017.

MeSH terms